Speer L. Monoclonal Antibodies for Alzheimer Disease: a Lack of Clinically Meaningful Benefits, Plus Significant Harms. Am Fam Physician. 2024 May;109(5):478-479. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.